ISRG
Intuitive Surgical, Inc. Common Stock
$378.85
장중 · Vol 153.4K · 52주 $328.57–$603.88 · 기준 2026. 8. 21. PM 3:59 ET
일봉 $367.04 · Aug 31, 2026
ISRG 가격 추세
종가
$367.04
시가
$370.29
고가
$370.29
저가
$365.32
30초 브리핑
ISRG 오늘의 판단 요약
보유 데이터를 비교 가능한 문장으로 해석한 요약입니다.
52주 범위의 18%
연중 저점권입니다. 반등 신호보다 하락 원인을 먼저 확인하세요.
Forward P/E 31.2배
선행 P/E가 낮아 시장은 이익 증가를 반영하고 있습니다.
20일 평균의 1.0배
거래량은 최근 평균 범위입니다.
2026-10-20
실적 전후 변동성 확대 가능성이 있으므로 컨센서스 범위와 옵션 기대변동을 함께 보세요.
펀더멘털 기준 Sep 1, 2026 · 규칙 기반 요약이며 투자 조언이 아닙니다.
핵심 통계
ISRG 일봉·펀더멘털 스냅샷 기준 주요 지표
펀더멘털 스냅샷 Sep 1, 2026
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
1020 Kifer Road · Sunnyvale, CA, United States · 직원 17,021명
시가총액
$135.02B
Trailing P/E
43.2
최근 12개월 이익 기준
Forward P/E
31.2
이익 증가 기대 반영
EPS (TTM)
$8.72
배당 수익률
—
배당성향
0.0%
베타
1.46
시장보다 민감
ROE
17.4%
P/B
7.34
EV/EBITDA
30.3
52주 범위
$328.57 – $603.88
현재 위치 18%
거래량
2.01M
20일 평균 2.03M · 1.0배
애널리스트 의견
매수 73%
총 33명 · 0m
DITM LEAPS Analysis
ISRG 장기 DITM 콜옵션을 진입 적합도 순으로 비교
| Contract | Expiry | Strike | Price | Lev. | Delta | Extrinsic | Spread | IV | OI | Score | 상세 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ISRG280121C00210000 | 1/21/28 · 1.4Y | $210.00 | $186.00 | 1.8x | 0.9037 | 10.3% | 4.30% | 56.67% | 15 | 74.94 | |
| ISRG280121C00200000 | 1/21/28 · 1.4Y | $200.00 | $194.00 | 1.8x | 0.9136 | 8.8% | 5.15% | 57.71% | 1 | 73.85 | |
| ISRG280121C00220000 | 1/21/28 · 1.4Y | $220.00 | $180.50 | 1.9x | 0.8885 | 13.1% | 4.99% | 58.20% | 7 | 70.15 | |
| ISRG280121C00230000 | 1/21/28 · 1.4Y | $230.00 | $172.50 | 1.9x | 0.8782 | 14.9% | 5.22% | 56.79% | 6 | 68.03 | |
| ISRG280121C00250000 | 1/21/28 · 1.4Y | $250.00 | $157.50 | 2.0x | 0.8545 | 19.4% | 5.71% | 54.70% | 17 | 64.22 | |
| ISRG280121C00240000 | 1/21/28 · 1.4Y | $240.00 | $165.50 | 2.0x | 0.8657 | 17.3% | 5.44% | 56.27% | 2 | 64.19 | |
| ISRG280121C00260000 | 1/21/28 · 1.4Y | $260.00 | $147.95 | 2.1x | 0.8451 | 21.0% | 5.34% | 51.78% | 13 | 62.99 | |
| ISRG280121C00270000 | 1/21/28 · 1.4Y | $270.00 | $143.00 | 2.2x | 0.8285 | 25.3% | 5.59% | 52.69% | 3 | 57.13 | |
| ISRG280121C00280000 | 1/21/28 · 1.4Y | $280.00 | $136.50 | 2.3x | 0.8139 | 29.0% | 6.59% | 52.13% | 14 | 55.02 | |
| ISRG280121C00290000 | 1/21/28 · 1.4Y | $290.00 | $129.50 | 2.3x | 0.7995 | 32.9% | 6.95% | 51.09% | 9 | 51.31 | |
| ISRG280121C00300000 | 1/21/28 · 1.4Y | $300.00 | $123.00 | 2.4x | 0.7842 | 37.5% | 6.50% | 50.32% | 72 | 49.88 | |
| ISRG270917C00300000 | 9/17/27 · 1.0Y | $300.00 | $111.00 | 2.7x | 0.7854 | 30.8% | 5.41% | 50.61% | 1 | 47.84 | |
| ISRG280121C00310000 | 1/21/28 · 1.4Y | $310.00 | $116.50 | 2.5x | 0.7661 | 42.6% | 7.73% | 52.54% | 14 | 42.83 | |
| ISRG270917C00310000 | 9/17/27 · 1.0Y | $310.00 | $106.00 | 2.7x | 0.7640 | 36.9% | 9.43% | 52.67% | 1 | 40.56 | |
| ISRG280121C00320000 | 1/21/28 · 1.4Y | $320.00 | $110.50 | 2.6x | 0.7503 | 48.5% | 8.14% | 51.82% | 25 | 39.06 |
재무제표
ISRG 연간 손익·현금흐름·재무상태
매출 성장률
+20.5%
최근 연간 YoY
EPS 성장률
+22.6%
최근 연간 YoY
영업이익률
29.3%
최근 연간
FCF 마진
24.7%
잉여현금흐름 / 매출
매출 추세
순이익 추세
잉여현금흐름 추세
| 항목 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| 매출 | $10.06B+20.5% | $8.35B+17.2% | $7.12B+14.5% | $6.22B | — |
| 매출총이익 | $6.64B+17.9% | $5.63B+19.1% | $4.73B+12.7% | $4.20B | — |
| 영업이익 | $2.95B+25.4% | $2.35B+32.9% | $1.77B+12.0% | $1.58B | — |
| 순이익 | $2.86B+23.0% | $2.32B+29.2% | $1.80B+36.0% | $1.32B | — |
| 희석 EPS | $7.87+22.6% | $6.42+27.6% | $5.03+37.8% | $3.65 | — |
| EBITDA | $3.62B+27.2% | $2.85B+28.2% | $2.22B+14.3% | $1.94B | — |
| 영업현금흐름 | $3.03B+25.5% | $2.42B+33.1% | $1.81B+21.7% | $1.49B | — |
| 잉여현금흐름 | $2.49B+91.0% | $1.30B+73.9% | $749.60M-21.8% | $958.40M | — |
| 총자산 | $20.46B+9.2% | $18.74B+21.4% | $15.44B+19.0% | $12.97B | — |
| 총부채 | — | — | — | — | $87.00M |
최신 연도 우선 · 작은 퍼센트는 직전 연도 대비 변화입니다.
캘린더
ISRG 실적·배당 일정
매출 하단
$2.85B
EPS 하단
$2.53
매출 상단
$2.99B
실적 발표일
2026-10-20
D-49
EPS 상단
$2.76
매출 컨센서스
$2.91B
EPS 컨센서스
$2.64
뉴스
ISRG 관련 최신 기사
제품·기술Intuitive Surgical, Inc. (ISRG) Gains As Market Dips: What You Should Know
In the most recent trading session, Intuitive Surgical, Inc. (ISRG) closed at $372.6, indicating a +1.51% shift from the previous trading day.
Zacks · Aug 28, 2026
실적Integra (IART) Down 1.6% Since Last Earnings Report: Can It Rebound?
Integra (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks · Aug 28, 2026
일반Can ISRG Stock Defend Its $131B Valuation?
This is a market-broadening year for Intuitive Surgical. The company is expanding beyond its core da Vinci systems to serve a wider continuum of hospitals and surgery centers.
Trefis · Aug 28, 2026
실적Is Intuitive Surgical (ISRG) Below Fair Value After Strong Revenue And Procedure Growth?
Intuitive Surgical (ISRG) has been back in focus after reporting another quarter of double digit revenue and procedure growth, supported by adoption of its da Vinci 5, single port system and Ion lung biopsy platform. Despite the strong quarterly update, Intuitive Surgical’s share price has been under pressure, with the stock down 34.09% on a year to date share price return and down 21.38% on a 1-year total shareholder return. This contrasts with its 16.27% total shareholder return over three...
Simply Wall St. · Aug 27, 2026
제품·기술3 Healthcare Stocks with Promising Prospects
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 24.9% gain over the past six months, beating the S&P 500 by 13.3 percentage points.
StockStory · Aug 27, 2026
일반Intuitive Surgical's Record Cash Flow Gives It an Innovation Advantage
ISRG's record cash flow is fueling R&D, manufacturing expansion and over 100 da Vinci 5 updates, strengthening its innovation edge.
Zacks · Aug 27, 2026
실적ISRG vs. MDT: Which Surgical Robot Stock Is the Smarter Buy?
Intuitive Surgical leads surgical robotics with faster procedure growth and recurring revenue, while Medtronic offers a cheaper, diversified growth profile.
Zacks · Aug 26, 2026
실적Why Is OPKO Health (OPK) Down 9.7% Since Last Earnings Report?
OPKO Health (OPK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks · Aug 26, 2026
- 일반
Eli Lilly Is Pulling Away From the Rest of Healthcare
Its growth profile stands well above major sector peers.
GuruFocus.com · Aug 25, 2026
일반The Hospital Bet That Reframes The Intuitive Surgical Stock Story
While investors fixate on a slowdown in current procedures, hospitals are accelerating their investment in the company's core platform, revealing a crucial, under-appreciated strength.
Trefis · Aug 25, 2026
홀더
ISRG 내부자·기관 보유 현황
최신 보고 목록 기준이며 실제 거래 시점과 보고일 사이에는 시차가 있습니다.
기관 보유
89.6%
기관 보유 (유동주식)
90.1%
내부자 보유
0.5%
기관 수
3,145
주요 기관 홀더
| 홀더 | 주식 수 | 평가액 | 지분 | 변동 | 보고일 |
|---|---|---|---|---|---|
| Blackrock Inc. | 30.02M | $11.32B | 8.5% | -0.2% | Jun 30, 2026 |
| Vanguard Capital Management LLC | 23.13M | $8.72B | 6.6% | 0.2% | Jun 30, 2026 |
| State Street Corporation | 16.06M | $6.05B | 4.6% | 1.4% | Jun 30, 2026 |
| Invesco Ltd. | 11.84M | $4.46B | 3.4% | 5.8% | Jun 30, 2026 |
| Price (T.Rowe) Associates Inc | 11.26M | $4.24B | 3.2% | -10.1% | Jun 30, 2026 |
| Geode Capital Management, LLC | 8.53M | $3.22B | 2.4% | 0.8% | Jun 30, 2026 |
| Capital World Investors | 7.74M | $2.92B | 2.2% | -3.8% | Jun 30, 2026 |
| Vanguard Portfolio Management LLC | 7.24M | $2.73B | 2.0% | 0.1% | Jun 30, 2026 |
| Morgan Stanley | 6.56M | $2.47B | 1.9% | 8.3% | Jun 30, 2026 |
| NORGES BANK | 4.95M | $1.87B | 1.4% | -1.8% | Jun 30, 2026 |
면책조항: 증시가격은 모든 주식 시장의 최신 증시가격을 표시하는 것은 아니며, 정보가 지연되거나 잘못될 수 있습니다. 거래 목적이나 조언이 아닌 정보 제공 목적으로만 제공됩니다.